Faeth Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 18.75 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 484.51M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company’s pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. The company was formerly known as Sensei Biotherapeutics, Inc. and changed its name to Faeth Therapeutics, Inc. in June 2026. The company was incorporated in 1999 and is headquartered in Rockville, Maryland.
Details
| Name | Faeth Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 29 |
| Founded | 1999 |
| Ipo Date | 2021-02-04 |
| Ceo | Anand Parikh |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US81728A2078 |
| Cusip | 81728A207 |
| Cik | 1829802 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Anand Parikh Esq., J.D. | Chief Executive Officer, President and Chair |
| Josiah Craver CPA | Senior Vice President of Finance, Principal Financial Officer and Principal Accounting Officer |
| Christopher W. Gerry J.D. | General Counsel and Secretary |
| Dr. Siddhartha Mukherjee DPHIL, M.D., Ph.D. | Scientific Co-Founder |
| Dr. Lewis clayton Cantley Ph.D. | Scientific Co-Founder |
| Dr. Scott W. Lowe Ph.D. | Scientific Co-Founder |
| Dr. Gregory J. Hannon Ph.D. | Scientific Co-Founder |
| Dr. Karen H. Vousden Ph.D. | Scientific Co-Founder and Director |
| Oliver Maddocks Ph.D. | Co-Founder and Chief Scientific Officer |
| Dr. Benjamin Hopkins Ph.D. | Scientific Co-Founder |
Contact
| Address | 1405 Research Boulevard, Suite 125, Rockville, Maryland 20850, United States |
| Phone | 240 243 8000 |
| Website | https://www.faeththerapeutics.com |